To include your compound in the COVID-19 Resource Center, submit it here.

Xenogen, Bristol-Myers tech transfer deal

BMY non-exclusively licensed real-time, biophotonic imaging

Read the full 69 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE